Please login to the form below

Not currently logged in
Email:
Password:

Dicerna appoints chief financial officer

Jack Green to take on the role on a permanent basis

Dicerna Jack GreenUS biopharmaceutical firm Dicerna has appointed Jack Green as its chief financial officer.

Green has been serving as the company's interim chief financial officer since January this year and will now take on the role on a permanent basis.

Dr Douglas Fambrough, Dicerna's president and chief executive, said: “I am very pleased to announce Jack as permanent CFO, as he brings to Dicerna a wealth of knowledge in finance and a strong track-record with public biotech companies.

“Since joining the company as interim CFO, Jack's strategic and business insights have added tremendous value and will be instrumental to the continued growth of Dicerna.”

Green has over 30 years of financial management experience, over twenty of which he gained in the biotechnology sector.

He has served as the chief financial officer of GTC Biotherapeutics and Verastem, as well as vice president, finance of On-Q-ity, a US biotechnology company.

Green said: “Dicerna has made great progress developing an exciting pipeline of clinical-stage oncology and rare disease product candidates as well as an emerging pipeline of DsiRNA-EX conjugate programmes for liver-targeted diseases.

“I look forward to contributing to Dicerna's success as we advance these programmes through clinical development and to working closely with the management team and board of directors.”

25th April 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics